Yoshimatsu Rika, Yamagami Takuji, Terayama Koshi, Matsumoto Tomohiro, Miura Hiroshi, Nishimura Tsunehiko
Department of Radiology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Department of Radiology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Chest. 2009 Apr;135(4):1002-1009. doi: 10.1378/chest.08-1499. Epub 2008 Nov 18.
In daily clinical work, we often face delayed or recurrent pneumothorax after radiofrequency (RF) ablation for lung tumors, but a large study on this theme has not been done. Thus, we examined the rate of delayed or recurrent pneumothorax after RF ablation for lung tumors and the risk factors associated with its occurrence.
This retrospective study was based on 194 consecutive sessions of percutaneous RF ablation of 220 lung tumors in 68 patients performed under CT fluoroscopic guidance at a single institution. Numerous variables were analyzed to the assess risk factors for delayed or recurrent pneumothorax.
Pneumothorax after RF ablation occurred in 82 of 194 ablation sessions (42.3%). Thirty-three of 82 sessions had either delayed pneumothorax (n = 20) or recurrent pneumothorax (n = 13). The other 49 sessions had nonprogressive pneumothorax. Only contact of the ground-glass opacity (GGO) that emerged around the ablated lesion with the pleura significantly correlated with the frequency of delayed or recurrent pneumothorax in comparisons between no pneumothorax vs delayed/recurrent pneumothorax and between nonprogressive pneumothorax vs delayed/recurrent pneumothorax. The mean (+/- SD) duration before confirmation of the presence or recurrence of pneumothorax was 24.0 +/- 66.4 h. Among the 33 sessions with delayed or recurrent pneumothorax, 4 subjects needed additional treatment.
Our results indicated that delayed or recurrent pneumothorax is relatively frequently encountered after RF ablation of lung tumors. Particular care must be taken with regard to the occurrence of delayed or recurrent pneumothorax when contact of a GGO with the pleura is seen after RF ablation.
在日常临床工作中,我们经常遇到肺肿瘤射频消融术后延迟性或复发性气胸,但尚未开展关于该主题的大型研究。因此,我们研究了肺肿瘤射频消融术后延迟性或复发性气胸的发生率及其发生的相关危险因素。
本回顾性研究基于在一家机构的CT透视引导下对68例患者的220个肺肿瘤进行的194次连续经皮射频消融治疗。分析了众多变量以评估延迟性或复发性气胸的危险因素。
194次消融治疗中有82次(42.3%)发生了射频消融术后气胸。82次治疗中有33次出现了延迟性气胸(n = 20)或复发性气胸(n = 13)。另外49次治疗为非进行性气胸。在无气胸与延迟性/复发性气胸以及非进行性气胸与延迟性/复发性气胸的比较中,仅消融灶周围出现的磨玻璃影(GGO)与胸膜接触与延迟性或复发性气胸的发生频率显著相关。确认气胸存在或复发前的平均(±标准差)持续时间为24.0±66.4小时。在33次延迟性或复发性气胸治疗中,4例患者需要额外治疗。
我们的结果表明,肺肿瘤射频消融术后延迟性或复发性气胸相对常见。当射频消融术后出现GGO与胸膜接触时,必须特别注意延迟性或复发性气胸的发生。